September 17, 2024Gene and cell therapies are at the forefront of medical breakthroughs, offering new possibilities for treating complex diseases. The success…
July 23, 2024Overview In the intricate world of drug development, the role of quality cannot be overstated. Ensuring the safety, efficacy, and…
May 23, 2024In the rapidly evolving pharmaceutical industry, the quality and safety of drug substances and products hinge significantly on the integrity…
April 27, 2023It’s imperative that biopharma organizations developing innovative treatments for rare diseases navigate the FDA’s Orphan Drug Designation (ODD) program. Since…
May 4, 2022May 4, 2022 | Nathaniel DiTommaso, MS, Regulatory Affairs Manager In May of 2014 and February of 2019, the FDA…
December 14, 2018December 14, 2018 | Kathryn Tworkoski, PhD, RAC, Senior Clinical Research Scientist │ Regulatory Affairs, Medical Writing, Drug Development Consulting Long-time readers…
April 20, 2018April 20, 2018 | Kasturi Puranam, PhD | Clinical Research Scientist II | Regulatory Affairs, Drug Development Consulting I hope…
March 14, 2018March 14, 2018 | Preeti Chugha, PhD, RAC | Clinical Research Scientist II | Regulatory Affairs, Drug Development Consulting You’ve…
February 16, 2018February 16, 2018 | Kathryn Tworkoski, PhD, RAC | Clinical Research Scientist II | Regulatory Affairs, Drug Development Consulting Introducing…
February 10, 2016February 10, 2016 | Chip Carnathan, PhD, RAC, Director Regulatory Affairs | Regulatory Affairs, Drug Development Consulting Yeah, yeah, we…
